Literature DB >> 30222077

ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux.

Marielle Margier1, Xavier Collet2, Cédric le May3, Charles Desmarchelier1, François André4, Chantal Lebrun5, Catherine Defoort1,6, Alice Bluteau5, Patrick Borel1, Anne Lespine5, Emmanuelle Reboul1.   

Abstract

Efficient intestinal absorption of dietary vitamin D is required in most people to ensure an adequate status. Thus, we investigated the involvement of ATP binding cassette subfamily B member 1 (ABCB1) in vitamin D intestinal efflux. Both cholecalciferol (D3) and 25-hydroxycholecalciferol [25(OH)D3] apical effluxes were decreased by chemical inhibition of ABCB1 in Caco-2 cells and increased by ABCB1 overexpression in Griptites or Madin-Darby canine kidney type II cells. Mice deficient for the 2 murine ABCB1s encoded by Abcb1a and Abcb1b genes ( Abcb1-/-) displayed an accumulation of 25(OH)D3 in plasma, intestine, brain, liver, and kidneys, together with an increased D3 postprandial response after gavage compared with controls. 25(OH)D3 efflux through Abcb1-/- intestinal explants was markedly decreased compared with controls. This reduction of 25(OH)D3 transfer from plasma to lumen was further confirmed in vivo in intestine-perfused mice. Docking experiments established that both D3 and 25(OH)D3 could bind with high affinity to Caenorhabditis elegans P-glycoprotein, used as an ABCB1 model. Finally, in a group of 39 healthy male adults, a single-nucleotide polymorphism (SNP) in ABCB1 (rs17064) was significantly associated with the fasting plasma 25(OH)D3 concentration. Thus, we showed here for the first time that ABCB1 is involved in neo-absorbed vitamin D efflux by the enterocytes and that it also contributes to vitamin D transintestinal excretion and likely impacts vitamin D status.-Margier, M., Collet, X., le May, C., Desmarchelier, C., André, F., Lebrun, C., Defoort, C., Bluteau, A., Borel, P., Lespine, A., Reboul, E. ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux.

Entities:  

Keywords:  25-hydroxycholecalciferol; MDR1; bioavailability; cholecalciferol; enterocyte

Mesh:

Substances:

Year:  2018        PMID: 30222077     DOI: 10.1096/fj.201800956R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

1.  Lactobacillus rhamnosus GG Promotes Intestinal Vitamin D Absorption by Upregulating Vitamin D Transporters in Senile Osteoporosis.

Authors:  Jing Cheng; Jianhua Zhai; Weilong Zhong; Jingwen Zhao; Lu Zhou; Bangmao Wang
Journal:  Calcif Tissue Int       Date:  2022-05-26       Impact factor: 4.000

Review 2.  Vitamin D and Obesity/Adiposity-A Brief Overview of Recent Studies.

Authors:  Imene Bennour; Nicole Haroun; Flavie Sicard; Lourdes Mounien; Jean-François Landrier
Journal:  Nutrients       Date:  2022-05-13       Impact factor: 6.706

3.  Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers.

Authors:  Hae Won Lee; Woo Youl Kang; Wookjae Jung; Mi-Ri Gwon; Kyunghee Cho; Backhwan Lee; Sook Jin Seong; Young-Ran Yoon
Journal:  Clin Pharmacol Drug Dev       Date:  2022-01-04

4.  Functional characterization of nutraceuticals using spectral clustering: Centrality of caveolae-mediated endocytosis for management of nitric oxide and vitamin D deficiencies and atherosclerosis.

Authors:  Anton Franz Fliri; Shama Kajiji
Journal:  Front Nutr       Date:  2022-08-15

5.  Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.

Authors:  Simon Hsu; Leila R Zelnick; Yvonne S Lin; Cora M Best; Bryan Kestenbaum; Kenneth E Thummel; Lynn M Rose; Andrew N Hoofnagle; Ian H de Boer
Journal:  J Am Soc Nephrol       Date:  2020-10-28       Impact factor: 14.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.